Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biohaven (BHVN) Total Liabilities (2021 - 2026)

Biohaven has reported Total Liabilities over the past 6 years, most recently at $336.9 million for Q1 2026.

  • Quarterly results put Total Liabilities at $336.9 million for Q1 2026, up 68.92% from a year ago — trailing twelve months through Mar 2026 was $336.9 million (up 68.92% YoY), and the annual figure for FY2025 was $399.4 million, up 108.36%.
  • Total Liabilities reached $336.9 million in Q1 2026 per BHVN's latest filing, down from $399.4 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $426.3 million in Q3 2025 and bottomed at -$46.1 million in Q1 2022.
  • Median Total Liabilities over the past 5 years was $146.3 million (2023), compared with a mean of $177.1 million.
  • Peak annual rise in Total Liabilities hit 577.96% in 2023, while the deepest fall reached 30.71% in 2023.
  • Over 5 years, Total Liabilities stood at $123.0 million in 2022, then tumbled by 30.71% to $85.2 million in 2023, then skyrocketed by 124.87% to $191.7 million in 2024, then surged by 108.36% to $399.4 million in 2025, then dropped by 15.64% to $336.9 million in 2026.
  • Business Quant data shows Total Liabilities for BHVN at $336.9 million in Q1 2026, $399.4 million in Q4 2025, and $426.3 million in Q3 2025.